Red Flags Detected
- Going Concern (new) — Company discloses substantial doubt about ability to continue operations beyond 12 months due to insufficient cash to fund planned operations.
- Delisting (new) — Received Nasdaq delisting notice in February 2025 for bid price below $1.00 for 30 consecutive days, though subsequently regained compliance.
Oncolytics reports promising cancer trial data but warns of going concern doubt
Filed March 30, 2026 · Period ending December 31, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade ONCY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 4, 2026 1:07 AM